Ref. 08-2021 Pathologist in Breast and Prostate Cancer Translational Research (Process Closed)

HR_logo

The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Pathologist in Breast and Prostate Cancer Translational Research” (Process Closed)

 

Reference: Ref. 08-2021

Application deadline: April 20, 2021

Number of vacancies: 1

Job description:

(A research pathologist position is available immediately at the Molecular Oncology Group at the Vall d’Hebron Institute of Oncology (PI: Paolo Nuciforo), Barcelona, Spain. In collaboration with the Groups of Violeta Serra, PhD and Joaquin Mateo, MD, PhD, we look for a highly-motivated research pathologist to support the team in the following tasks:

  • Translational research projects (50%). The candidate will be involved in the implementation of a biomarker for PARP inhibitors. Specifically, he/she will:
    • Be in charge of research sample qualification (H&E assessment) and immunofluorescence(IF)-based and immunohistochemistry(IHC)-based biomarkers evaluation;
    • Interpret the results generated and present data to the team;
    • Participate to project meetings.
  • Clinical research projects (50%). The candidate will provide support to laboratory activities related to clinical trials open at our institution. Specifically, he/she will:
    • supervise technicians’ in assay development tasks;
    • score IHC stained slides using either manual and/or image analysis tools available in the lab;
    • write study reports;
    • Present results to the team and pharma.
    • Participate to project meetings.

Our groups have a long tradition in studying and testing hypothesis-based targeted therapy in different cancer types. Our research is committed to the clinical implications of our findings in relation to ongoing and future clinical trials. The candidate will work in close contact with a multidisciplinary team of molecular biologist, medical oncologist, pathologist, bioinformaticians, and study coordinators, participating to institutional task forces and supporting the molecular prescreening program.  The duration of the position is 2 years with the possibility of contract extension. PhD thesis is encouraged.

Requirements:

We are looking for a research pathologist (MD with board certification in pathology) with background in cancer biology. Candidacy for ESMO-funded fellowships will be preferred. Fluency in English is mandatory.

Application:

Please email a cover letter with scientific interests, CV, and names and contact information for 2-3 references to: selecciorrhh@vhio.net. Please use “Ref. 08-2021 Research Pathologist Molecular Oncology Group” as the subject line in your email.

About VHIO:

Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.

Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.

VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.

VHIO’s translation toward precision oncology: https://www.vhio.net

Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.

On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.

Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.